Filing Details
- Accession Number:
- 0000950170-25-043849
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-24 16:15:37
- Reporting Period:
- 2025-03-20
- Filing Date:
- 2025-03-24
- Accepted Time:
- 2025-03-24 16:15:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1658551 | Amylyx Pharmaceuticals Inc. | AMLX | Pharmaceutical Preparations (2834) | 464600503 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1971421 | G Bernhardt Zeiher | C/O Amylyx Pharmaceuticals, Inc. 43 Thorndike Street Cambridge MA 02141 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-20 | 10,000 | $3.70 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.65 to $3.73. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
Billionaire Hedge Funds
